肝癌介入治疗的精准选择与合理应用OA北大核心CSTPCD

Interventional therapy for hepatocellular carcinoma(HCC)plays a crucial role in managing intermediate and advanced stages of the disease.It encompasses various techniques,including transarterial chemoembolization(TACE),selective internal radiation therapy(SIRT),hepatic arterial infusion chemotherapy(HAIC),radiofrequency ablation(RFA),and microwave ablation(MWA).The rational application of these techniques is essential for effective treatment across different stages of HCC.In recent years,the concept of refined TACE has gained acceptance,emphasizing precision in procedures to enhance therapeutic efficacy and minimize adverse effects.Addressing TACE resistance by promptly adjusting treatment strategies is necessary to optimize patient outcomes.China has made innovative advances in interventional therapy for HCC,such as the development of 125I seed stents and multifunctional microspheres,offering new technological options that improve treatment outcomes.In future practice,combining TACE with targeted therapy and immunotherapy is considered an effective approach for treating advanced HCC,and capable of modulating the local immune microenvironment of tumors and enhancing overall treatment efficacy.These innovations and combined therapeutic strategies can improve patient survival and advance the development of HCC treatment.